TEACHERS ADVISORS, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 133 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$11,810,000
+9.7%
733,517
-0.3%
0.01%
-6.7%
Q4 2018$10,767,000
-8.0%
735,938
+14.2%
0.02%
+114.3%
Q3 2018$11,704,000
+117.9%
644,182
+102.3%
0.01%0.0%
Q2 2018$5,372,000
+2.3%
318,453
+18.8%
0.01%0.0%
Q1 2018$5,251,000
+10.8%
268,026
+14.5%
0.01%
+16.7%
Q4 2017$4,741,000
+23.4%
234,025
+5.8%
0.01%
+20.0%
Q3 2017$3,842,000
+46.4%
221,194
+8.0%
0.01%
+25.0%
Q2 2017$2,625,000
+6.3%
204,786
+7.5%
0.00%0.0%
Q1 2017$2,469,000
-65.6%
190,502
-73.8%
0.00%
-63.6%
Q4 2016$7,176,000
-17.6%
726,329
+0.7%
0.01%
-21.4%
Q3 2016$8,710,000
+39.8%
721,044
-0.1%
0.01%
+27.3%
Q2 2016$6,230,000
-6.8%
721,934
+2.2%
0.01%
-8.3%
Q1 2016$6,687,000
+149.8%
706,111
+357.1%
0.01%
+140.0%
Q4 2015$2,677,000
+30.3%
154,466
+0.9%
0.01%
+25.0%
Q3 2015$2,055,000
-41.1%
153,014
-0.9%
0.00%
-33.3%
Q2 2015$3,487,000
+64.9%
154,437
+4.3%
0.01%
+50.0%
Q1 2015$2,114,000
+51.3%
148,046
+2.2%
0.00%
+33.3%
Q4 2014$1,397,000
+6.0%
144,7990.0%0.00%0.0%
Q3 2014$1,318,000
-7.9%
144,7990.0%0.00%0.0%
Q2 2014$1,431,000
-18.8%
144,799
+4.3%
0.00%
-25.0%
Q1 2014$1,763,000
-10.3%
138,808
+5.9%
0.00%0.0%
Q4 2013$1,965,000
+44.6%
131,058
+6.5%
0.00%
+33.3%
Q3 2013$1,359,000
+42.6%
123,098
+2.6%
0.00%0.0%
Q2 2013$953,000119,9940.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders